F

Fulcrum Therapeutics

92 employees

Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.

Basic info

Industry

biotechnology research

Sectors

Gene Regulation
Biotechnology
Cardiovascular Diseases
Health Care
Neuromuscular Diseases
Therapeutics
Genetics
Rare Genetic Diseases

Date founded

2016

Funding rounds raised

Total raised

$80M

from 13 investors over 13 rounds

F

Fulcrum Therapeutics raised $69M on June 9, 2020

Investors: Foresite Capital, Samsara BioCapital, Monashee Investment Management LLC, Perceptive Advisors and Casdin Capital, LLC

F

Fulcrum Therapeutics raised $80M on September 5, 2018

Investors: NS Investment, 6 Dimensions Capital, Leerink Partners LLC, Research Division, Casdin Capital, LLC, Section 32 and Foresite Capital

F

Fulcrum Therapeutics raised $5M on May 10, 2017

Investors: GV

F

Fulcrum Therapeutics raised $55M on July 19, 2016

Investors: Third Rock Ventures

FAQ